Postbiotic Nagqu4580 Attenuates Ulcerative Colitis and Suppresses Ferroptosis in Association with the Microbiota-Tryptophan-AhR/Nrf2 Axis.

What To Know

A preclinical journal abstract reports that a fermented product named postbiotic Nagqu4580 reduced disease measures in a mouse model of acute ulcerative colitis (DSS-induced).

The study measured inflammation, colon damage, epithelial barrier proteins, markers of lipid peroxidation and ferroptosis (MDA, 4‑HNE, GSH/GSSG, GPX4, ACSL4), serum tryptophan metabolites, activation of AhR and Nrf2 pathways, and gut microbiota composition.

Authors report that Nagqu4580 dose-dependently lessened clinical and histologic colitis, decreased inflammatory cytokines, restored tight junction proteins, reduced biochemical signs of ferroptosis, shifted tryptophan metabolites (e.g., increased 5‑HIAA, decreased 3‑IS), partially corrected DSS-associated dysbiosis, and activated AhR/Nrf2 antioxidant signaling.

These results come from an animal model and laboratory measurements reported in the article abstract; they do not represent clinical evidence in people with UC. The findings suggest mechanistic links among the microbiota, tryptophan metabolism, AhR/Nrf2 signaling, and inhibition of ferroptosis as a route for postbiotic effects.

If you are a patient, do not change or start treatments based on this preclinical report; discuss any interest in probiotics or postbiotics with your care team.